TargED Eyes 2024 Clinic Entry For Clot Buster On Back Of Financing
€39m Raised In Series A
The Dutch firm expects the financing to advance its novel asset Microlyse into a potentially pivotal study for a rare blood disorder.
The Dutch firm expects the financing to advance its novel asset Microlyse into a potentially pivotal study for a rare blood disorder.